Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis

Published:2023-07-27 Issue:2 Volume:55 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Patel Tirath¹,Nageeta Fnu²,Sohail Rohab³,Butt Tooba Shaukat⁴,Ganesan Shyamala¹,Madhurita Fnu⁵,Ahmed Muhammad⁶,Zafar Mahrukh⁷,Zafar Wirda⁷,Zaman Mohammad Uzair⁸,Varrassi Giustino⁹,Khatri Mahima¹⁰^ORCID,Kumar Satesh¹¹^ORCID

Affiliation:

1. Medicine, American University of Antigua, Antigua and Barbuda

2. Medicine, Ghulam Muhammad Mahar Medical College, Sukkur, Pakistan

3. Medicine, Quaid-e-Azam Medical College Bahawalpur, Pakistan, Pakistan

4. Medicine, United Medical and Dental College, Karachi, Pakistan

5. Medicine, Chanda Medical College, Larkana, Pakistan

6. Medicine, American University of the Carribean, United States of America

7. Medicine, University of Medicine and health sciences, St. Kitts, Carribean, United States of America

8. Medicine, Bacha Khan Medical College, Mardan, Pakistan

9. Anesthesiology, Paolo Procacci Foundation, Rome, Italy

10. Medicine, Dow University of Health Sciences, Karachi, Pakistan

11. Medicine, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, Pakistan